Newron Pharmaceuticals SpA (NP5.DE) Stock Price

€7.51 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    1

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Newron Pharmaceuticals SpA, AI stock picks, stock alerts and much more.

Sign up

NP5.DE AI Stock Analysis

AI stock analysis for NP5.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Newron Pharmaceuticals SpA (NP5.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Newron Pharmaceuticals SpA (NP5.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Newron Pharmaceuticals SpA (NP5.DE), currently trading at €7.51, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About NP5.DE

LSE

  • Newron Pharmaceuticals SpA operates as a biopharmaceutical company.

  • Symbol

    NP5.DE

  • Market

    XETRA

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    149.9M

Similar Stocks

W8A.DE Walgreens Boots Alliance Inc
W8A.DE		 €9.68
0.2%
4
RDC.DE Redcare Pharmacy NV
RDC.DE		 €128.5
0.1%
6
2LYA.F High Tide Inc.
2LYA.F		 €2.09
2.5%
5

News

No news articles.

NP5.DE Alternative Data

Web Traffic

Newron Pharmaceuticals SpA receives an estimated 3091 monthly visitors to newron.com.

  • Web Traffic

    3091

  • Change from Previous Month

    12.3%

  • 3 Month Change

    27.9%

News Mentions

Newron Pharmaceuticals SpA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Newron Pharmaceuticals SpA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

LinkedIn Followers

6,671 are following Newron Pharmaceuticals SpA on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    6671

  • Daily Change

    0.1%

  • 1 Month Change

    1%

  • 3 Month Change

    2.6%

LinkedIn Employees

According to LinkedIn, Newron Pharmaceuticals SpA has 23 employees.

  • LinkedIn Employees

    23

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

NP5.DE Financials

NP5.DE Key Metrics

  • Total Revenue

    €3.4M

  • Net Income

    -€9.6M

  • Earnings per Share

    -€0.51

  • Free cash flow

    -€8.8M

  • EBITDA

    -€7.6M

  • EBITDA Ratio

    -2.22689

  • Total Assets

    €24.9M

NP5.DE 2-year Revenue & Income
NP5.DE 2-year Free Cash Flow

NP5.DE Technicals

NP5.DE SMA
NP5.DE RSI

FAQ

What's the current price of Newron Pharmaceuticals SpA (NP5.DE) Stock?
The price of an Newron Pharmaceuticals SpA (NP5.DE) share is €7.51.

What's the market cap of Newron Pharmaceuticals SpA?
The current market cap of Newron Pharmaceuticals SpA is 149.9M.

Should I buy or sell NP5.DE?
Newron Pharmaceuticals SpA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Newron Pharmaceuticals SpA is better viewed as a hold or accumulate position while waiting for further developments.

Is Newron Pharmaceuticals SpA a good investment?
The current analysis of Newron Pharmaceuticals SpA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Newron Pharmaceuticals SpA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Newron Pharmaceuticals SpA (NP5.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Newron Pharmaceuticals SpA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Newron Pharmaceuticals SpA (NP5.DE) that investors often compare it to?
Newron Pharmaceuticals SpA (NP5.DE) is often compared to similar stocks such as Walgreens Boots Alliance Inc, Redcare Pharmacy NV and High Tide Inc..

What is the forecast for Newron Pharmaceuticals SpA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Newron Pharmaceuticals SpA's stock price to be around €7.25 in 2026. Starting from the current price of €7.51, this represents a 3.5% change in price, indicating a neutral outlook for the stock.

How to buy Newron Pharmaceuticals SpA (NP5.DE) Stock?
Newron Pharmaceuticals SpA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Newron Pharmaceuticals SpA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.